Long-Term Outcomes of a Therapist-Supported, Smartphone-Based Intervention for Elevated Symptoms of Depression and Anxiety: Quasiexperimental, Pre-Postintervention Study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Background: Depression is one of the most common mental health disorders and severely impacts one’s physical, psychological, and social functioning. To address access barriers to care, we developed Ascend—a smartphone-delivered, therapist-supported, 8-week intervention based on several evidence-based psychological treatments for depression and anxiety. A previous feasibility study with 102 adults with elevated depression reported that Ascend is associated with a postintervention reduction in depression symptoms. Objective: We aimed to examine whether Ascend is associated with a reduction in symptoms of anxiety, and importantly, whether reductions in symptoms of depression and anxiety are maintained up to 12-months postintervention. Methods: We assessed whether the previously reported, end-of-treatment improvements seen in the 102 adults with elevated symptoms of depression extended up to 12 months posttreatment for depression symptoms (measured by the Patient Health Questionnaire-9 [PHQ-9]) and up to 6 months posttreatment for anxiety symptoms (added to the intervention later and measured using the Generalized Anxiety Disorder-7 [GAD-7] scale). We used linear mixed effects models with Tukey contrasts to compare time points and reported intention-to-treat statistics with a sensitivity analysis. Results: The intervention was associated with reductions in symptoms of depression that were maintained 12 months after the program (6.67-point reduction in PHQ-9 score, 95% CI 5.59-7.75; P<.001; Hedges g=1.14, 95% CI 0.78-1.49). A total of 60% of the participants with PHQ-9 scores above the cutoff for major depression at baseline (PHQ≥10) reported clinically significant improvement at the 12-month follow-up (at least 50% reduction in PHQ-9 score and postprogram score <10). Participants also reported reductions in symptoms of anxiety that were maintained for at least 6 months after the program (4.26-point reduction in GAD-7 score, 95% CI 3.14-5.38; P<.001; Hedges g=0.91, 95% CI 0.54-1.28). Conclusions: There is limited evidence on whether outcomes associated with smartphone-based interventions for common mental health problems are maintained posttreatment. Participants who enrolled in Ascend experienced clinically significant reductions in symptoms of depression and anxiety that were maintained for up to 1 year and 6 months after the intervention, respectively. Future randomized trials are warranted to test Ascend as a scalable solution to the treatment of depression and anxiety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008) · Medical Care · doi:10.1097/mlr.0b013e318160d093 · Cited by 4,527 · cited 1×
“The GAD-7 has excellent reliability and internal consistency (Cronbach α of 0.89) and has been validated in both the general population and primary care settings [44,45].”
InfluentialDepression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
The effect of mindfulness based therapy on anxiety and depression: A meta analytic review
Hofmann, S. G., Sawyer, A. T., Witt, A. A., & Oh, D. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0018555 · Cited by 3,846 · cited 1×
“Although there are several effective pharmacological [7] and psychological [8,9] treatments for depression, less than half of all individuals who require treatment actually receive it [10,11].”
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
The prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884 · cited 1×
“Nevertheless, such assumptions are inherently unverifiable, and recent guidelines highlight the importance of minimizing the likelihood of incomplete outcome data [64].”
Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: A meta-analysis
SPEK, V., CUIJPERS, P., NYKLÍČEK, I., RIPER, H., KEYZER, J., & POP, V. (2007) · Psychological Medicine · doi:10.1017/s0033291706008944 · Cited by 1,586
Löwe, B., Kroenke, K., Herzog, W., & Gräfe, K. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00198-8 · Cited by 1,558 · cited 1×
“A similar yet more liberal definition for clinically significant change was also proposed by Löwe and colleagues [43] as a PHQ-9 score reduction of ≥ 5.”
Hoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420
Barriers to mental health treatment: results from the WHO World Mental Health surveys
Andrade, L. H., Alonso, J., Mneimneh, Z., Wells, J. E., Al-Hamzawi, A., Borges, G., Bromet, E., Bruffaerts, R., de Girolamo, G., de Graaf, R., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291713001943 · Cited by 1,289 · cited 1×
“Although there are several effective pharmacological [7] and psychological [8,9] treatments for depression, less than half of all individuals who require treatment actually receive it [10,11].”
Validation of PHQ-2 and PHQ-9 to Screen for Major Depression in the Primary Care Population
Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn, J., Kerse, N., Fishman, T., Falloon, K., & Hatcher, S. (2010) · The Annals of Family Medicine · doi:10.1370/afm.1139 · Cited by 1,279 · cited 1×
“The PHQ-9 has excellent internal consistency (Cronbach α of 0.89 in primary care settings) and excellent test-retest reliability [41].”
InfluentialSmartphones for smarter delivery of mental health programs: A systematic review
Donker, T., Petrie, K., Proudfoot, J., Clarke, J., Birch, M.-R., & Christensen, H. (2013) · Journal of Medical Internet Research · doi:10.2196/jmir.2791 · Cited by 1,136 · cited 2×
“…flexible usage at a self-determined time and pace, which is thought to enhance self-efficacy [24]; monitoring of activity, symptoms, and progression in real time; provision of personalized feedback, motivational support, and targeted care; and potential to improve adherence to treatment [25].”
Firth, J., Torous, J., Nicholas, J., Carney, R., Pratap, A., Rosenbaum, S., & Sarris, J. (2017) · World Psychiatry · doi:10.1002/wps.20472 · Cited by 1,097 · cited 2×
“Our analysis revealed a larger effect size for the reduction in depression symptoms 12 months postintervention ( g =1.14) than was reported by a recent meta-analysis [26] comparing smartphone-based interventions for depression to inactive control groups ( g =0.56).”
InfluentialPsychotherapy for depression in adults: A meta-analysis of comparative outcome studies.
Cuijpers, P., van Straten, A., Andersson, G., & van Oppen, P. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0013075 · Cited by 1,050 · cited 1×
“Although there are several effective pharmacological [7] and psychological [8,9] treatments for depression, less than half of all individuals who require treatment actually receive it [10,11].”
Behavioral activation treatment for depression: returning to contextual roots
Jacobson, N. S., Martell, C. R., & Dimidjian, S. (2001) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.8.3.255 · Cited by 1,011 · cited 1×
“…consists of 8 modules delivered sequentially over an 8-week period, which include content derived from evidence-based practices such as mindfulness-based stress reduction [35], mindfulness-based cognitive therapy [36], cognitive-behavioral therapy [37], and behavioral activation therapy [38].”
Premature discontinuation in adult psychotherapy: A meta-analysis
Swift, J. K., & Greenberg, R. P. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0028226 · Cited by 978 · cited 1×
“Further, up to 75% of patients referred to in-person psychotherapy either do not enter treatment or discontinue treatment prematurely [18,19].”
Spijkerman, M. P. J., Pots, W. T. M., & Bohlmeijer, E. T. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.03.009 · Cited by 975
Mental Health Smartphone Apps: Review and Evidence-Based Recommendations for Future Developments
Bakker, D., Kazantzis, N., Rickwood, D., & Rickard, N. (2016) · JMIR Mental Health · doi:10.2196/mental.4984 · Cited by 886
Prevention of Relapse following cognitive therapy vs medications in moderate to severe depression.
Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Young, P. R., Haman, K. L., Freeman, B. B., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.417 · Cited by 735
Firth, J., Torous, J., Nicholas, J., Carney, R., Rosenbaum, S., & Sarris, J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.046 · Cited by 675 · cited 2×
“Preliminary evidence suggests that smartphone-based interventions are a promising means to treat depression and anxiety, with recent meta-analyses reporting small-to-moderate reductions in clinical symptoms across 27 studies [26,27].”
InfluentialKroenke, K., Wu, J., Yu, Z., Bair, M. J., Kean, J., Stump, T., & Monahan, P. O. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000322 · Cited by 504 · cited 1×
“A clinically significant improvement in anxiety symptoms has previously been defined as a GAD-7 score reduction of ≥ 3 [46].”
Perceived barriers to psychological treatments and their relationship to depression
Mohr, D. C., Ho, J., Duffecy, J., Baron, K. G., Lehman, K. A., Jin, L., & Reifler, D. (2010) · Journal of Clinical Psychology · doi:10.1002/jclp.20659 · Cited by 347 · cited 1×
“Barriers to treatment include financial and time constraints, long wait periods, a shortage of trained professionals, and fear of stigmatization [12,13].”
Păsărelu, C. R., Andersson, G., Bergman Nordgren, L., & Dobrean, A. (2017) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2016.1231219 · Cited by 335 · cited 4×
“Further, a recent meta-analysis reported a similar uncontrolled effect size of g =1.29 for the reduction in depression symptoms associated with transdiagnostic, internet-delivered cognitive-behavioral therapy for depression and anxiety at follow-up [33].”
InfluentialCBT for depression: a pilot RCT comparing mobile phone vs. computer
Watts, S., Mackenzie, A., Thomas, C., Griskaitis, A., Mewton, L., Williams, A., & Andrews, G. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-49 · Cited by 329 · cited 1×
“Indeed, the large effect reported here is consistent with other within-group (uncontrolled) effect sizes for app-and online-based depression interventions [55-57].”
A Systematic Review of Cognitive Behavioral Therapy and Behavioral Activation Apps for Depression
Huguet, A., Rao, S., McGrath, P. J., Wozney, L., Wheaton, M., Conrod, J., & Rozario, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154248 · Cited by 328 · cited 1×
“First, few authors report on the outcomes of commercially developed smartphone-based interventions for depression and anxiety, making it difficult to evaluate their utility [25,28].”
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299 · cited 1×
“When treated with antidepressants, an estimated 30%-50% of patients do not experience significant symptom reduction [14], up to 80% of patients report at least one mild-to-severe side effect [15], and few patients maintain a state of long-term remission [16].”
Barriers to psychotherapy among depressed and nondepressed primary care patients
Mohr, D. C., Hart, S. L., Howard, I., Julian, L., Vella, L., Catledge, C., & Feldman, M. D. (2006) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm3203_12 · Cited by 276
Proudfoot, J., Parker, G., Hadzi Pavlovic, D., Manicavasagar, V., Adler, E., & Whitton, A. (2010) · Journal of Medical Internet Research · doi:10.2196/jmir.1475 · Cited by 274 · cited 1×
“Smartphone ownership has seen rapid worldwide growth [21], and survey data suggest that smartphone-based interventions may be preferred over other online formats by health care consumers [22,23].”
Defining successful treatment outcome in depression using the PHQ-9: A comparison of methods
McMillan, D., Gilbody, S., & Richards, D. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.030 · Cited by 247 · cited 1×
“…study, Kroenke and colleagues [40] defined a clinically significant improvement in depression as a 50% reduction in the PHQ-9 score combined with a postintervention score of 10 (for participants with baseline scores ≥ 10), and this definition has been further validated in a comparison study [42].”
Reger, M. A., & Gahm, G. A. (2009) · Journal of Clinical Psychology · doi:10.1002/jclp.20536 · Cited by 234 · cited 1×
“…effect size reported here is consistent with the results from online (as opposed to app-based) psychological interventions for anxiety disorders [58,59] and is, in fact, slightly lower than the effect size reported by a recent meta-analysis [33] of transdiagnostic, internet-delivered…”
Torous, J., Chan, S. R., Yee-Marie Tan, S., Behrens, J., Mathew, I., Conrad, E. J., Hinton, L., Yellowlees, P., & Keshavan, M. (2014) · JMIR Mental Health · doi:10.2196/mental.4004 · Cited by 228
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv076 · Cited by 218 · cited 2×
“This is important because an estimated 50% or more of patients with major depression or generalized anxiety disorder will relapse within 6 to 12 months after the end of an initially effective treatment [30-32].”
Treating comorbid anxiety and depression: psychosocial and pharmacological approaches
Coplan, J. D. (2015) · World Journal of Psychiatry · doi:10.5498/wjp.v5.i4.366 · Cited by 207 · cited 2×
“The Ascend intervention was primarily intended to treat symptoms of depression; however, many individuals with depression also have comorbid symptoms of anxiety [17].”
Meyer, B., Bierbrodt, J., Schröder, J., Berger, T., Beevers, C. G., Weiss, M., Jacob, G., Späth, C., Andersson, G., Lutz, W., et al. (2015) · Internet Interventions · doi:10.1016/j.invent.2014.12.003 · Cited by 188
Ratitch, B., O'Kelly, M., & Tosiello, R. (2013) · Pharmaceutical Statistics · doi:10.1002/pst.1549 · Cited by 155 · cited 1×
“PMMs are based on a joint modeling of outcomes and missingness and can account for data that is “missing not at random” [50].”
Cuijpers, P., Cristea, I. A., Karyotaki, E., Reijnders, M., & Hollon, S. D. (2019) · Psychotherapy Research · doi:10.1080/10503307.2017.1395922 · Cited by 140
Online interventions for depression and anxiety – a systematic review
Saddichha, S., Al-Desouki, M., Lamia, A., Linden, I. A., & Krausz, M. (2014) · Health Psychology and Behavioral Medicine · doi:10.1080/21642850.2014.945934 · Cited by 133 · cited 1×
“The finding that Ascend was associated with reductions in symptoms of anxiety as well as depression is unsurprising, given that the intervention comprises evidence-based practices that have previously been shown to be effective at treating both conditions [60].”
Wilhelmsen, M., Lillevoll, K., Risør, M. B., Høifødt, R., Johansen, M.-L., Waterloo, K., Eisemann, M., & Kolstrup, N. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-296 · Cited by 133
Mechanisms of antidepressant resistance
El-Hage, W., Leman, S., Camus, V., & Belzung, C. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00146 · Cited by 111
Rickels, K., Etemad, B., Khalid-Khan, S., Lohoff, F. W., Rynn, M. A., & Gallop, R. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.170 · Cited by 63 · cited 2×
“This is important because an estimated 50% or more of patients with major depression or generalized anxiety disorder will relapse within 6 to 12 months after the end of an initially effective treatment [30-32].”
Steinglass (2017) · doi:10.1002/da.22624 · Cited by 54
Insufficient Dollars and Qualified Personnel to Meet United States Mental Health Needs
Weil, T. P. (2015) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000271 · Cited by 50 · cited 1×
“Barriers to treatment include financial and time constraints, long wait periods, a shortage of trained professionals, and fear of stigmatization [12,13].”
Grant, K., McMeekin, E., Jamieson, R., Fairfull, A., Miller, C., & White, J. (2012) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465811000476 · Cited by 30 · cited 1×
“Further, up to 75% of patients referred to in-person psychotherapy either do not enter treatment or discontinue treatment prematurely [18,19].”
Cited by
Knitza, J., Simon, D., Lambrecht, A., Raab, C., Tascilar, K., Hagen, M., Kleyer, A., Bayat, S., Derungs, A., Amft, O., et al. (2020) · JMIR mHealth and uHealth · doi:10.2196/19661 · Cited by 201
A therapist-guided smartphone app for major depression in young adults: A randomized clinical trial
Raevuori, A., Vahlberg, T., Korhonen, T., Hilgert, O., Aittakumpu-Hyden, R., & Forman-Hoffman, V. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.02.007 · Cited by 52
Self-citationThomas, E. B. K., Sagorac Gruichich, T., Maronge, J. M., Hoel, S., Victory, A., Stowe, Z. N., & Cochran, A. (2023) · JMIR Mental Health · doi:10.2196/43065 · Cited by 9
“One way to improve accessibility is through mobile health (mHealth) interventions. mHealth interventions have demonstrated effectiveness in a variety of conditions, including depression, anxiety, bipolar disorder, borderline personality disorder, and post-traumatic stress disorder [18-23].”
A Mixed-Methods Analysis of Mobile ACT Responses From Two Cohorts
Hoel, S., Victory, A., Sagorac Gruichich, T., Stowe, Z. N., McInnis, M. G., Cochran, A., & Thomas, E. B. K. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.869143 · Cited by 4
Sierra, M. A., & Ortiz, E. (2023) · Interdisciplinaria Revista de Psicología y Ciencias Afines · doi:10.16888/interd.2023.40.2.5 · Cited by 1
Metadata
- Authors
- Economides, M., Ranta, K., Nazander, A., Hilgert, O., Goldin, P. R., Raevuori, A., & Forman-Hoffman, V.
- Venue
- JMIR mHealth and uHealth
- Publisher
- JMIR Publications Inc.
- Published
- 2019-08-26
- Volume
- 7
- Issue
- 8
- Pages
- e14284
- ISSN
- 2291-5222 (ISSN-L)
- OpenAlex
- W2963627171
- Cited by
- 56
- References
- 44
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.